Acutus Medical Inc expected to post a loss of 69 cents a share - Earnings Preview

Acutus Medical

10/05/2023 03:03

* Acutus Medical Inc  AFIB.OQ   AFIB.O  is expected
to report 
results on May 11. 
    * The company's guidance on April 20 2023, for the period
ended
March 31, was for revenue between $4.10 million and $4.20
million.
    * ​Refinitiv's mean analyst estimate for Acutus Medical Inc
is for
a loss of 69 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Acutus
Medical
Inc is $1.75​, above​ its last closing price of $0.94. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.74       -0.71      0.41      Beat    158
 Sep. 30 2022  -0.82       -0.81      -0.72     Beat    10.9
 Jun. 30 2022  -0.82       -0.80      -1.38     Missed  -73.4​
 Mar. 31 2022  -0.94       -0.92      -1.00     Missed  -8.3
 ​​Dec.        -0.95       -0.83      -1.12     Missed  -34.1
 31 2021                                                
 Sep. 30 2021  -0.85       -0.87      -0.94     Missed  -8.5​
 Jun. 30 2021  -0.92       -0.84      -1.02     Missed  -21.7
 Mar. 31 2021  -0.85       -0.81      -1.04     Missed  -28.1
 This summary was machine generated May 10 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated